Suppr超能文献

[恶性胸腔积液的粘连治疗(胸膜腔内注射溶链菌制剂与米诺环素)]

[Adhesion therapy for malignant pleural effusion (intrapleural administration of OK-432 with minocycline)].

作者信息

Tanaka A, Sato T

机构信息

Department of Thoracic Surgery, Sapporo City General Hospital, Japan.

出版信息

Nihon Kokyuki Gakkai Zasshi. 1999 Jul;37(7):531-7.

Abstract

Eleven patients with massive effusion due to pleuritis carcinomatosa were treated by tube drainage, followed by instillation of OK-432 and minocycline for pleurodesis. Pleural immunological and chemical reactions of adhesion were strongly induced by the use of these adhesive agents. As a result, pleural effusion was diminished in all patients without recurrence, allowing the drainage tubes to be successfully removed. As severe adverse effects following this course of therapy, high fever was observed in all patients, and acute renal failure in one. Blood chemical data from the patients revealed an increase in the number of granulocytes with a high level of interleukin-6 one day after instillation. These findings suggested that the symptoms of general inflammation were induced by local pleural inflammation. The median survival period was 253.7 days for 5 patients who were sufficiently fit to be discharged from our hospital. This was better than the historical average for the patients with uncontrolled pleural effusion. In conclusion, it was possible to control malignant pleural effusion and achieve longer survival periods through the optimal management of tube drainage and instillation of adhesion-inducing agents.

摘要

11例癌性胸膜炎大量胸腔积液患者接受了胸腔闭式引流治疗,随后注入OK-432和米诺环素进行胸膜固定术。使用这些粘连剂强烈诱导了胸膜免疫和化学性粘连反应。结果,所有患者的胸腔积液均减少且无复发,引流管得以成功拔除。在此治疗过程中,出现了严重不良反应,所有患者均出现高热,1例出现急性肾衰竭。患者的血液化学数据显示,注入药物1天后粒细胞数量增加,白细胞介素-6水平升高。这些发现提示全身炎症症状是由局部胸膜炎症引起的。5例身体状况良好得以出院的患者中位生存期为253.7天。这优于胸腔积液未得到控制患者的历史平均生存期。总之,通过优化胸腔引流管理和注入粘连诱导剂,有可能控制恶性胸腔积液并实现更长生存期。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验